CD8 + T cells play essential roles in immunity to viral and bacterial infections, and to guard against malignant cells. The CD8 + T cell response to an antigen is composed of many T cell clones with unique T cell receptors, together forming a heterogenous repertoire of phenotypically and functionally distinct effector and memory cells 1,2 . How individual T cell clones contribute to this heterogeneity during an immune response is key to understand immunity but remains largely unknown. Here, we longitudinally tracked CD8 + T cell clones expanding in response to yellow fever virus vaccination at the single cell level in humans. We show that only a fraction of the clones detected in the acute response persists as circulating memory T cells, indicative of clonal selection. Clones persisting in the memory phase displayed biased differentiation trajectories along a gradient of stem cell memory (SCM) towards terminally differentiated effector memory (EMRA) fates. Reactivation of single memory CD8 + T cells revealed that they were poised to recapitulate skewed differentiation trajectories in secondary responses, and this was generalizable across individuals for both yellow fever and influenza virus. Together, we show that the sum of distinct clonal differentiation repertoires results in the multifaceted T cell response to acute viral infections in humans.
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Main
To assess how individual clones together shape the heterogeneous repertoire of CD8 + T cells during acute and memory phases of an anti-viral T cell response in humans, we tracked thousands of antigen-specific CD8 + T cells longitudinally during primary immune responses to the Yellow Fever Virus vaccine YFV-17D. This is a very efficient, live, attenuated viral vaccine generating lifelong adaptive immunity following a single injection [3] [4] [5] [6] [7] . We monitored single YFV-17D-specific CD8 + T cells specific for the immunodominant HLA-A2 restricted epitope (NS4b LLW) as well as a subdominant HLA-B7-restricted epitope (NS5 RPI), during acute (day 15), early memory (days 90-136), and late memory (day 500+) phases of the response ( Fig. 1a, Supplementary Figure 1a ) 6 . We identified productive TCRb sequences for 3058 cells using a nested PCR strategy, targeting the TCRb chain locus in DNA from whole genome amplified single cells 8, 9 , and an additional 1720 cells using full length scRNA-seq and TCRa and/or b chain identification in four healthy human donors (Donors A-D) ( Supplementary Table   1 ) 10,11 . As previously reported 6 , the HLA-A2 response was an order of magnitude greater than the HLA-B7 response (Fig. 1b ). Despite the difference in response magnitude, HLA-A2 and HLA-B7 responses displayed similar patterns of expansion and contraction ( Supplementary   Figure 1b , c). A significant drop in clonal diversity occurred during the transition from the acute (day 15) to memory phase of the response for all donors and epitopes (p<0.05) ( Fig. 1c ). Higher clonal diversity at day 15 was associated with increased frequency of responding cells (Fig.   1d ), indicating that the number of distinct naïve precursor cells recruited to the response determines the response magnitude. The decline in diversity over time indicates that clonal selection plays a role in shaping the circulating memory repertoire after YF-17D vaccination, consistent with focusing of the TCR repertoire observed in bulk analysis of cytomegalovirus (CMV) pp65-specific CD8 + T cells isolated from primary to chronic stages of CMV infection 12 . However, it is unclear whether expansion early in the response is an important determinant of selection into the memory repertoire. Adoptive transfer and lineage tracing studies in mice suggest that poorly expanded clones may preferentially persist as memory cells [13] [14] [15] , and extinction of some highly expanded clones has been observed in primary to chronic stages of CMV infection 12 , suggesting that not all highly expanded clones in the acute response transition into memory cells. Indeed, contraction of large clones and expansion of smaller clones was apparent during the acute to memory transition in two donors with datasets spanning the acute to late memory phases of the HLA-A2-restricted response (Fig. 1e ). Analysis of the relationship between clone size and persistence to the late memory phase (day 593 or 720) revealed that a large clone size at day 15 was negatively associated with long-term survival (log odds ratio: -1.76 donor A, -1.83 donor D, p<0.05) while a small clone size at day 90/136 was positively correlated with persistence to day 500+ (log odds ratio: 0.51 donor A, 0.73 donor D, p<0.05) (Supplementary Table 2 ). Our results highlight the stability of the clonal repertoire throughout the memory phase of the immune response and demonstrate that large clonal expansion during the acute response is not a prerequisite for selection into the long-lived memory repertoire, and may instead preclude memory differentiation.
Diverse memory and effector lineages are known to persist for decades after YFV vaccination, and are a hallmark of memory T cell immunity 5, 16, 17 . Although classically these populations have been viewed as discrete cell types, high dimensional analysis of CD8 + populations increasingly suggest that these cells exist in a spectrum of cell types ranging from CCR7 + central memory (CM) and stem cell memory (SCM) to highly differentiated CCR7effector memory (EM) and terminally differentiated EM (EMRA) 2, 18 . We examined the phenotypic heterogeneity of the acute and memory response for CD8 + T cells specific for the HLA-A2/NS4b LLW and HLA-B7/NS5 RPI epitopes in three donors using high-parameter flow cytometry. We measured expression of proteins associated with CM/SCM (CCR7, CD127, TCF-1, LEF1, CD27) 17,19-21 and EM/EMRA (granzyme A, granzyme B, CD94, CD57) 22,23 , in addition to CD45RA, KLRG1, CXCR4, and Ki67, and analyzed the heterogeneity using dimensionality reduction to clarify the distribution of YFV-specific CD8 + T cells across the spectrum of phenotypes over time 24 . The vast majority of acutely responding cells clustered together, between highly polarized effector memory and stem cell memory populations, and expressed effector proteins (granzymes A and B), yet were distinguished from memory populations on the basis of having lower expression of CD45RA and CXCR4 ( Fig. 2a , Supplementary Figure 2a ). By contrast, most cells at day 90 regained CD45RA expression and displayed increased phenotypic heterogeneity, covering the range of phenotypes between highly polarized SCM and EMRA fates ( Fig. 2b, Supplementary Figure 2a ). We noted clear interindividual differences in distribution of YFV-specific cells along the spectrum of memory identities ( Supplementary Figure 2b , c), whereas no major differences were observed between HLA-A2 or HLA-B7 restricted viral epitopes ( Supplementary Figure 2d ). The analysis also revealed the existence of intermediate phenotypes, e.g. a population of CD127 + CCR7 -CD8 + T cells with intermediate expression of TCF-1 and LEF-1 ( Supplementary Figure 2e , f), further supporting the notion that CD8 + T cell differentiation encompasses a spectrum of identities rather than discrete cell types.
Although our analysis of protein expression revealed that YFV-specific memory CD8 + T cells encompassed a range of phenotypes, it did not allow us to track the behavior of individual clones over time. To this end we combined cell surface protein expression analysis ( Supplementary Figure 3a , b, Supplementary Table 3 ) with high coverage single-cell RNAseq 11 . This approach both allowed us to identify distinct clones and to further refine the classification of cellular marker profiles, coupling clonality to phenotype. Two healthy subjects were monitored throughout the acute to memory transition, and one donor was selected for indepth clonal analysis. To quantify each cell's identity along the continuum of phenotypes we used a recently described partial least squares regression approach, with CCR7 protein expression as a starting point, to train a classifier for all sequenced YFV-specific CD8 + T cells ( Supplementary Figure 4a ) 25 . This allowed us to rank and assign a score to each CD8 + T cell based on transcriptome differences according to the likelihood that they were strong effector (pCM=0) or strong SCM cells (pCM=1.0) ( Supplementary Figure 4b-d ). We validated the pCM score on cells sorted from bulk CD8 + T cell populations on the basis of classically defined phenotypes (Naïve, SCM, CM, EM, EMRA) (Supplementary Figure 5) . Notably, many of the top genes identified by our classification strategy (TCF7, CCR7, LTB, SELL, GZMK, GZMB, GZMH, ZEB2, CCL4, GNLY) play established roles in specifying SCM and effector memory cell identities in mice and humans 2, 20, 26, 27 . In both donors we found that the pCM score accurately ordered cells according to expression of these genes ( Supplementary Figure 4b-d ).
For Donor A, for which three timepoints were collected, we analyzed how individual clones varied with respect to pCM score throughout the response (Fig. 2c ). In the acute phase of the response, most clones had low pCM scores, indicating an effector bias. In the early and late memory phase, we observed a gradual increase in pCM scores over time for cells in many of the clones, consistent with the idea that some clones transition via an effector stage to an SCM fate 3 . Focusing on the memory phase we found that not all clones, however, transitioned towards a SCM fate, as some gave rise exclusively to effector cells ( Fig. 2c, d ). Our findings thus reveal that distinct clonal fates in the memory phase of the response give rise to the overall phenotypic heterogeneity observed in long-lived CD8 + T cell memory repertoires.
Secondary infections result in a rapid mobilization of memory T cell subsets to produce a diverse population of effector cells. The current model postulates that CM/SCM act as a pluripotent, self-renewing population which gives rise to all effector cell classes 21,28,29 , whereas EM/EMRA only are capable of short bursts of highly cytotoxic effector cells 17,30,31 . However, it is not possible to infer properties at the single cell level from bulk analysis. To address how different memory T cell types respond at the single cell level, we performed antigen-specific reactivation of sorted, individual YFV-specific memory CD8 + T cells isolated from the memory population (day 136) and assessed the phenotype and heterogeneity of their clonal progeny by flow cytometry and scRNAseq. We characterized the response of 9 unique clones identified as SCM (clones B4, E4, H2), CD127 + EMRA (clones A7, A8, G6) or CD127 -EMRA (clones F3, G8, H9) which represent the range of memory identities observed in our study ( Fig. 3a, b) .
After a 20-day expansion period we detected thousands of progeny from each clone, all of which were CCR7 -CD127and which expressed variable levels of PD-1 and CD57, indicating their status as highly activated effectors ( Fig. 3c ). Notably we observed higher PD-1 expression in progeny derived from EMRA compared to SCM ( Fig. 3c ), suggesting a stronger predisposition of EMRA-derived progeny to develop senescent or 'exhausted' phenotypes in recall responses 32 . In contrast to EMRA-derived clones, SCM-derived and CD127 + EMRAderived T cell clones displayed signs of proliferation even 20 days post-activation ( Supplementary Figure 6a ), in line with the view that SCM cells undergo greater expansion in recall responses 21 .
We performed scRNAseq on 36-45 cells in the progeny from each clone to define the phenotypic heterogeneity at the single cell level within and between clones. After accounting for cell cycle differences, we examined intra-and inter-clonal variability of effector progeny according to gene expression differences by diffusion map dimensionality reduction ( Fig. 3d ) 33 .
This revealed distinct clonal gene expression signatures of effector progeny derived from different founder cells. We observed that clonal effector progeny generally separated on the basis of founder cell phenotype, albeit with cells once again ordering along a continuum of identities as opposed to discrete cell types. There were however exceptions; clone E4, which had a clear SCM founder phenotype, produced progeny more similar to progeny from CD127 + EMRA founders, while clone A7, a clone derived from a CD127 + EMRA progenitor, produced progeny similar to those from SCM founders (Fig. 3d ). The observation that different memory T cell clones could yield distinct effector progeny, despite exhibiting stereotypical SCM phenotypes, also provides a potential explanation for how heterogeneous secondary responses can be generated after reactivation of bulk SCM populations 19,21 . Analysis of differentially expressed genes between progeny from SCM and EMRA founders identified an enrichment of classical effector genes (IFNG, CCL3, CCL4, CCL5) in EMRA-derived progeny, while there was an enrichment of genes involved in lymphocyte homing (CXCR3, GPR15, ITGB1, CCR2, SELL) in SCM-derived progeny ( Fig. 3e, Supplementary Figure 6b , c, Supplementary Table 4 ).
We identified SELL (CD62L) and KLRD1 (CD94) as cell surface markers which generally segregated SCM-and EMRA-derived progeny. In additional experiments we observed that progeny of single activated clones often expressed either CD62L or CD94 ( Fig. 3f ). Based on our findings, we propose a model in which the long-lived memory repertoire consists of clones with divergent phenotypes, that give rise to a range of distinct effector cell types after reactivation ( Supplementary Figure 8 ). To test whether divergent clonal phenotypes was a generalizable phenomenon shared also in recall response to other viruses, we designed an experiment to measure responses by memory CD8 + T cell populations against an additional acute infection (Influenza) and a chronic infection, CMV, in parallel to responses to YFV. We identified three healthy HLA-A2 + individuals with detectable levels of both HLA-A2/YFVand HLA-A2/Influenza (M158-66; GILGFVFTL)-specific CD8 + T cells, two of which also had detectable levels of CMV (pp65; NLVPMVATV)-specific CD8 + T cells. We labeled total peripheral blood mononuclear cells (PBMCs) from each donor with CellTrace violet (CTV) and stimulated one million PBMCs with each viral peptide in parallel. After two weeks we observed the presence of expanded, antigen-specific CD8 + T cells for each viral antigen ( Supplementary Figure 9a) . We phenotyped the expanded T cells for each donor/virus combination using CD62L and CD94 expression and analyzed triplicates of 50 sorted CTV -Dextramer + CD8 + T cells from CD62L + CD94and CD62L -CD94 + subsets using RNAseq ( Fig.  4a , Supplementary Figure 9b ). Differential gene expression analysis of CD62L + CD94versus CD62L -CD94 -CD8 + T cells specific for YFV and Influenza revealed a clear segregation of the two populations across donors and anti-viral responses ( Fig. 4b , Supplementary Table 5) ). Gene expression differences were similar to our clonal scRNAseq experiments, with CD62L + CD94cells expressing elevated levels of genes related to homing (GPR15, S1PR1, KLF2) and CD62L -CD94 + cells expressing elevated levels of effector-associated genes (CCL3, CCL4, CCL5, TNF, NKG7) ( Fig. 4b) . In contrast to the YFV and influenza-specific CD8 + T cells, we detected substantially less differences between CD62L + CD94and CD62L -CD94 + CMV-specific CD8 + T cells, possibly reflecting a larger overlap in effector identities in the setting of chronic viral exposure ( Supplementary Figure 9c ).
To determine whether the CD62L + CD94and CD62L -CD94 + populations from each virusspecific CD8 + T cell population also had distinct clonal compositions we analyzed the distribution of TCRb sequences between samples ( Fig. 4c , Supplementary Table 6 ). YFVspecific responses were characterized by a higher number of unique clones relative to influenza and CMV specific responses in all donors (Fig. 4c ). The CD62L + CD94and CD62L -CD94 + populations, in both YFV-and influenza-specific effector cells, largely contained unique and non-overlapping clones ( Fig. 4c, d ), demonstrating that averaging of distinct clonal differentiation trajectories contributes to the phenotypic heterogeneity in recall responses in both YFV and influenza infection. In contrast to YFV and influenza, CMV responses were characterized by substantial clonal overlap between the two populations ( Fig. 4c, d ), suggesting that chronic antigen exposure can lead to subclonal diversification and thus increased clonal heterogeneity, or possibly promote the differentiation of polyfunctional clones.
Different models have been proposed to explain the existence of phenotypically distinct memory T cell subsets after infections 34 . Here we demonstrate that clonal selection after the acute phase shapes the repertoire of circulating memory CD8 + T cells, leaving clones undergoing biased differentiation trajectories towards distinct memory phenotypes along the continuum of SCM to EMRA identities. Clonally biased differentiation fates were also observed after reactivation at the single level, suggesting that different memory T cell clones play distinct roles in secondary immune responses. Recent evidence suggests that circulating effector cells may act as precursors for tissue-resident memory CD8 + T cells 35 104  188  127  150  240  118  55   153  230  75  82  176  88  192   95  61  100  149  112  64  107   130  142  79  224  98  81  67   160  92  129  189  72  106  102   74  222  108  122  109  280  162   240   106  129  79  224  92  98  112  95  222  107  109  281  122  100  150  104  130  188  55  127  75   118  230   103  102  74  149  142  108 .
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B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 B4 H2 A7 E4 G6 G8 A8 F3 H9 a, Cell cycle analysis of single cell RNAseq data reveals that progeny from SCM and CD127 + EMRA founders contain more dividing cells compared to CD57 + EMRA founders even after 20 days of expansion in vitro. Cell cycle analysis was carried out using Seurat. b, Heatmap depicting differentially expressed genes between progeny of SCM and EMRA founder cells. c, Expression of selected genes associated with memory and effector CD8 + T cells reveals that progeny from all clones display characteristics of effector cells, including lack of CCR7, IL7R, and TCF-7, and expression of GZMA, GZMB, PRF1 and GNLY, yet are distinguishable by expression of chemokines and homing receptors. After vaccination a number of unique naïve CD8 + T cells recognize HLA class I/YFV-peptide complexes on the surface of antigen presenting cells, leading to massive clonal expansions. Some clones persist throughout the memory phase of the response, and exhibit biased fate trajectories (clones A, B, D, E, F), whereas others are no longer detectable at this stage despite large expansion in the acute phase of the response (clone C). Together, the distinct clonal identities combine to form the heterogenous repertoire of memory CD8 + T cells. Upon rechallenge with the antigen (2° response), memory CD8 + T cells are activated and expand, producing a range of phenotypically distinct effector CD8 + T cell types which vary between clones but tend to be similar within any given clone. In general SCM-derived progeny proliferate more and produce progeny with a bias towards expressing genes related to homing/adhesion (e.g. SELL, CD52, GPR15), whereas EMRA-derived progeny are biased towards expression of chemokines (CCL3, CCL4, CCl5). 
